Antiobesity activity in high fat diet-induced obese Sprague-Dawley rat assessed as reduction of food intake at 10 mg/kg, po administered daily for 3 days relative to dirlotapide
Antiobesity activity in high fat diet-induced obese Sprague-Dawley rat assessed as reduction in body weight at 10 mg/kg, po administered daily for 3 days relative to dirlotapide
Antiobesity activity in high fat diet-induced obese Sprague-Dawley rat assessed as reduction of triglyceride accumulation in liver at 10 mg/kg, po administered daily for 3 days relative to dirlotapide
Antiobesity activity in high fat diet-induced obese Sprague-Dawley rat assessed as reduction of food intake at 1 mg/kg, po administered daily for 3 days relative to dirlotapide
Antiobesity activity in high fat diet-induced obese Sprague-Dawley rat assessed as reduction in body weight at 1 mg/kg, po administered daily for 3 days relative to dirlotapide
Antiobesity activity in high fat diet-induced obese Sprague-Dawley rat assessed as triglyceride accumulation in liver at 1 mg/kg, po administered daily for 3 days relative to dirlotapide
Antiobesity activity in high fat diet-induced obese Sprague-Dawley rat assessed as reduction of food intake at 3 mg/kg, po administered daily for 3 days relative to dirlotapide
Antiobesity activity in high fat diet-induced obese Sprague-Dawley rat assessed as reduction in body weight at 3 mg/kg, po administered daily for 3 days relative to dirlotapide
Antiobesity activity in high fat diet-induced obese Sprague-Dawley rat assessed as triglyceride accumulation in liver at 3 mg/kg, po administered daily for 3 days relative to dirlotapide
Antiobesity activity in high fat diet-induced obese Sprague-Dawley rat assessed as reduction of food intake at 30 mg/kg, po administered daily for 3 days relative to dirlotapide
Antiobesity activity in high fat diet-induced obese Sprague-Dawley rat assessed as reduction in body weight at 30 mg/kg, po administered daily for 3 days relative to dirlotapide
Antiobesity activity in high fat diet-induced obese Sprague-Dawley rat assessed as triglyceride accumulation in liver at 30 mg/kg, po administered daily for 3 days relative to dirlotapide
Antiobesity activity in high fat diet-induced obese Sprague-Dawley rat assessed as reduction of food intake at 100 mg/kg, po administered daily for 3 days relative to dirlotapide
Antiobesity activity in high fat diet-induced obese Sprague-Dawley rat assessed as reduction in body weight at 100 mg/kg, po administered daily for 3 days relative to dirlotapide
Antiobesity activity in high fat diet-induced obese Sprague-Dawley rat assessed as triglyceride accumulation in liver at 100 mg/kg, po administered daily for 3 days relative to dirlotapide
Antiobesity activity in po dosed high fat diet-induced obese Sprague-Dawley rat assessed as reduction of reduction of triglyceride accumulation in liver administered daily for 3 days
Antiobesity activity in high fat diet-induced obese Sprague-Dawley rat assessed as reduction of triglyceride accumulation in liver at 10 mg/kg, po administered with 25% SDD formulation daily for 3 days relative to control
Antiobesity activity in high fat diet-induced obese Sprague-Dawley rat assessed as reduction of food intake at 10 mg/kg, po administered with 25% SDD formulation daily for 3 days relative to control